Esperion Therapeutics
ESPR
#6143
Rank
โ‚น82.30 B
Marketcap
โ‚น347.17
Share price
-3.96%
Change (1 day)
82.12%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น82.30 Billion

As of December 2025 Esperion Therapeutics has a market cap of โ‚น82.30 Billion. This makes Esperion Therapeutics the world's 6143th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น82.30 B113.56%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Dec 23rd, 2025 the market cap of Esperion Therapeutics was reported to be:

โ‚น82.99 Billion
by Nasdaq info icon info icon
โ‚น82.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น294.62 B 257.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.050 T 1,176.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น12.657 T 15,279.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.446 T 8,947.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น393.26 B 377.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น39.34 B-52.20%๐Ÿ‡บ๐Ÿ‡ธ USA